The Alpha Laboratories team will be out and about at the following Conferences and Exhibitions:
SMA Autumn Meeting
9th-10th November 2018
University of Stirling
Come and see us at the SMA Autumn meeting to discuss our high quality microbiology products that help improve the speed and accuracy of disease diagnosis. Our range provides a comprehensive resource for the clinical microbiologist.
26th-27th November 2018
Bournemouth International Centre
Visit us on stand 60 to discuss our new product ADXBLADDER, a non-invasive urine test that can be used to detect minichromosome maintenance protein 5 (MCM5) in human urine to aid detection of bladder cancer in patients presenting with haematuria and/or recurrent lower urinary tract symptoms with a suspicion of malignancy.
BSG Annual Meeting
17-20 June 2019
With a long tradition in providing diagnostics for digestive health management, Alpha Laboratories invites BSG visitors to stand No. 42 to discuss the innovative products that are now available for this patient-pathway.
The BÜHLMANN IBDoc® is a CE marked assay allowing IBD positive patients to perform quantitative calprotectin tests in the comfort of their own home. Results are communicated to the clinician via smartphone technology enabling a customised, patient centric approach for therapy. Come and discuss how this approach can provide patient privacy, reassurance and involvement in disease management. See how the IBDoc can also be used to help triage valuable clinic space to those most in need.
The BÜHLMANN Quantum Blue® rapid Anti-TNF drug monitoring assays can also enable tailored therapy, resulting in improved patient care and cost effectiveness by allowing timely decision making for dose adjustments before the next infusion.
NICE have recently reviewed Faecal Haemoglobin testing using FIT to triage patients with low risk of colorectal cancers. Come and discuss how your clinic can benefit from the HM-JACKarc system. There are a number of hospitals in the UK now using this technology with a cut-off of 10µgHb/g faeces, which has a high NPV for cancer (100%) and other serious bowel disease (94%), making it an effective method of reducing colonoscopy referrals.
We would welcome the opportunity to demonstrate these products on the stand, or if you would like to evaluate in your clinic or hospital then come and talk to us.
ACB Focus 2018
On 7th June at ACB Focus, Alpha Laboratories sponsored a workshop: ‘FIT to Practice?’ which was chaired by Professor Callum Fraser and presented by Nigel D’Souza and Sally Benton. Nigel D’Souza presented preliminary data on the NICE FIT study, the largest multi-centre FIT trial in England, whilst Sally Benton discussed the technical capabilities and clinical outcomes from FIT Testing in the symptomatic.
Digestive Diseases Day 2017
On the 15th November Alpha Laboratories held a Digestive Diseases Day workshop in birmingham. This educational day brought together experts in the field to discuss recent advances in clinical diagnostics for gastroenterology, covering symptomatic FIT and faecal calprotectin implementation.
You can watch these presentations here.